Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer.

Karatas OF, Guzel E, Suer I, Ekici ID, Caskurlu T, Creighton CJ, Ittmann M, Ozen M.

PLoS One. 2014 Jun 26;9(6):e98675. doi: 10.1371/journal.pone.0098675. eCollection 2014.

PMID:
24967583
[PubMed - in process]
Free PMC Article
2.

Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.

Guzel E, Karatas OF, Semercioz A, Ekici S, Aykan S, Yentur S, Creighton CJ, Ittmann M, Ozen M.

Int J Cancer. 2014 Jun 28. doi: 10.1002/ijc.29054. [Epub ahead of print]

PMID:
24976077
[PubMed - as supplied by publisher]
3.

Circulatory miR-628-5p is downregulated in prostate cancer patients.

Srivastava A, Goldberger H, Dimtchev A, Marian C, Soldin O, Li X, Collins SP, Suy S, Kumar D.

Tumour Biol. 2014 May;35(5):4867-73. doi: 10.1007/s13277-014-1638-1. Epub 2014 Jan 30.

PMID:
24477576
[PubMed - indexed for MEDLINE]
4.

MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214.

Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen LN, Li X, Berry DL, Kallakury BV, Chauhan SC, Collins SP, Suy S, Kumar D.

PLoS One. 2013 Oct 22;8(10):e76994. doi: 10.1371/journal.pone.0076994. eCollection 2013.

PMID:
24167554
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.

Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N.

J Hum Genet. 2012 Nov 26;57(11):691-9. doi: 10.1038/jhg.2012.95. Epub 2012 Aug 2.

PMID:
22854542
[PubMed - indexed for MEDLINE]
6.

Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy.

Sun X, Liu Z, Yang Z, Xiao L, Wang F, He Y, Su P, Wang J, Jing B.

Diagn Pathol. 2013 Dec 18;8:208. doi: 10.1186/1746-1596-8-208.

PMID:
24350576
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Epithelial and stromal expression of miRNAs during prostate cancer progression.

Ren Q, Liang J, Wei J, Basturk O, Wang J, Daniels G, Gellert LL, Li Y, Shen Y, Osman I, Zhao J, Melamed J, Lee P.

Am J Transl Res. 2014 Jul 18;6(4):329-39. eCollection 2014.

PMID:
25075250
[PubMed]
Free PMC Article
8.

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.

Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K.

Int J Cancer. 2010 Mar 1;126(5):1166-76. doi: 10.1002/ijc.24827.

PMID:
19676045
[PubMed - indexed for MEDLINE]
9.

Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.

Li X, Wan X, Chen H, Yang S, Liu Y, Mo W, Meng D, Du W, Huang Y, Wu H, Wang J, Li T, Li Y.

Clin Cancer Res. 2014 May 1;20(9):2312-25. doi: 10.1158/1078-0432.CCR-13-1588. Epub 2014 Mar 7.

PMID:
24610824
[PubMed - in process]
10.

Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer.

Watahiki A, Macfarlane RJ, Gleave ME, Crea F, Wang Y, Helgason CD, Chi KN.

Int J Mol Sci. 2013 Apr 10;14(4):7757-70. doi: 10.3390/ijms14047757.

PMID:
23574937
[PubMed]
Free PMC Article
11.

miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.

Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu YP, Gui QJ, Zhang L, Li GQ.

Oncol Rep. 2014 Apr;31(4):1715-22. doi: 10.3892/or.2014.3052. Epub 2014 Feb 24.

PMID:
24573489
[PubMed - in process]
12.

miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.

Duan FT, Qian F, Fang K, Lin KY, Wang WT, Chen YQ.

Mol Cancer. 2013 Dec 13;12:164. doi: 10.1186/1476-4598-12-164.

PMID:
24330809
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.

PMID:
23741026
[PubMed - indexed for MEDLINE]
14.

Identification of circulating microRNA signatures for breast cancer detection.

Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS.

Clin Cancer Res. 2013 Aug 15;19(16):4477-87. doi: 10.1158/1078-0432.CCR-12-3401. Epub 2013 Jun 24.

PMID:
23797906
[PubMed - indexed for MEDLINE]
Free Article
15.

Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.

Schubert M, Spahn M, Kneitz S, Scholz CJ, Joniau S, Stroebel P, Riedmiller H, Kneitz B.

PLoS One. 2013 Jun 14;8(6):e65064. doi: 10.1371/journal.pone.0065064. Print 2013.

PMID:
23798998
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
[PubMed - indexed for MEDLINE]
17.

Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy.

Casanova-Salas I, Rubio-Briones J, Calatrava A, Mancarella C, Masiá E, Casanova J, Fernández-Serra A, Rubio L, Ramírez-Backhaus M, Armiñán A, Domínguez-Escrig J, Martínez F, García-Casado Z, Scotlandi K, Vicent MJ, López-Guerrero JA.

J Urol. 2014 Feb 8. pii: S0022-5347(14)00232-8. doi: 10.1016/j.juro.2014.01.107. [Epub ahead of print]

PMID:
24518785
[PubMed - as supplied by publisher]
18.

MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.

Lin ZY, Huang YQ, Zhang YQ, Han ZD, He HC, Ling XH, Fu X, Dai QS, Cai C, Chen JH, Liang YX, Jiang FN, Zhong WD, Wang F, Wu CL.

Int J Cancer. 2014 Aug 1;135(3):541-50. doi: 10.1002/ijc.28707. Epub 2014 Jan 10.

PMID:
24382668
[PubMed - indexed for MEDLINE]
19.

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2012 Feb 21;14(1):R34.

PMID:
22353773
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.

Novello C, Pazzaglia L, Cingolani C, Conti A, Quattrini I, Manara MC, Tognon M, Picci P, Benassi MS.

Int J Oncol. 2013 Feb;42(2):667-75. doi: 10.3892/ijo.2012.1717. Epub 2012 Nov 28.

PMID:
23229283
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk